Drug Topics

JULY 17, 2024

The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.

209

209

STAT

JULY 17, 2024

Vaccination lowers the chance of developing long Covid, according to a large new study that also found that the risk of serious complications has diminished but not disappeared as new coronavirus variants emerged. The study, published Wednesday in the New England Journal of Medicine , compared the health records of more than 440,000 Veterans Affairs patients who were infected with Covid-19 with records of more than 4 million uninfected people.

Vaccines 145

Vaccines 145

Drug Topics

JULY 17, 2024

“If people think COVID is no big deal and decide to forgo vaccinations, they’re essentially doubling their risk of developing long COVID,” wrote investigators.

Vaccines 131

Vaccines 131

STAT

JULY 17, 2024

Around the world, patients suddenly can’t find enough of the insulins made by companies they have long relied on to do so. In the U.S., Novo Nordisk’s recent decision to discontinue a product has left patients with fewer options. At the same time, patients are encountering shortages of other products from Novo and Eli Lilly. For months, pharmacies have been running out of vials of certain insulins that patients use to fill the pumps they wear on their body.

144

144

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JULY 17, 2024

Healthcare costs are set to rise between 7% and 8% in 2025, according to a new report from PwC. | Healthcare costs are set to rise between 7% and 8% in 2025, according to a new report from PwC.

131

131

STAT

JULY 17, 2024

As a hematologist-oncologist in Miami, Mikkael Sekeres always hopes his patients will find a perfect match for the bone marrow transplant they need to save their lives — but he doesn’t expect it. Most of his patients are Latino or African American, and rates of perfect matches are much lower for racial or ethnic minorities. That gloomy picture could soon change.

141

141

STAT

JULY 17, 2024

Taking the oral examination is the final step in becoming a board-certified obstetrician and gynecologist (OB-GYN). It is a challenge in the best of circumstances. But instead of worrying about how to respond to questions about the management of uterine cancers or peripartum hemorrhage, test candidates are worried about the legal risks of taking this exam, which must be done in Dallas, home of the American Board of Obstetrics and Gynecology (ABOG).

133

133

Pharmacy Times

JULY 17, 2024

A patient with severe and recurrent pemphigus vulgaris achieved lasting remission with a novel intravenous immunoglobulin preparation that had the added benefit of reducing treatment-related side effects.

123

123

STAT

JULY 17, 2024

Wall Street’s reaction was swift Wednesday after Elevance Health said that the amount of care its Medicaid members are getting is outpacing what states are paying the insurer to treat those members. Elevance’s stock tumbled almost 6% even though the company reported earnings that beat Wall Street’s estimates, and a slightly higher operating gain in the second quarter of 2024 compared with the prior-year period.

Insurance 131

Insurance 131

Fierce Healthcare

JULY 17, 2024

Grocery delivery company Instacart continues to expand its reach in healthcare and has notched a major health system partnership. | The first program to launch integrates Instacart Health tools into Northwell’s Center for Maternal Health Maternal Outcomes and Morbidity Collaborative (MOMS) so that moms-to-be who are food insecure have improved access to fresh and nutritious food.

128

128

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Topics

JULY 17, 2024

Patients with childhood type 1 diabetes were more likely to develop substance use disorders, mood disorders, anxiety disorders, and behavioral syndromes.

112

112

STAT

JULY 17, 2024

Gilead Sciences’ chief medical officer will leave the company early next year as the drugmaker struggles to find new areas of growth beyond its core portfolio of HIV medicines. Merdad Parsey, who joined Gilead in 2019, will stay in his post until the first quarter of next year as the company looks for a successor, Gilead said in a press release Wednesday.

125

125

Pharmacy Times

JULY 17, 2024

Radiotherapy may have applications beyond symptomatic relief when used in combination with immunotherapy.

132

132

STAT

JULY 17, 2024

For scientists and medical professionals well versed in the safety and effectiveness of vaccines, it is often too easy to write off the concerns of people who fear them, or feel they have been injured by them. But vaccine expert Kizzmekia S. Corbett-Helaire argues that professionals should be more empathetic when it comes to listening to these concerns, and that understanding them may help developers make better vaccines.

Vaccines 124

Vaccines 124

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

JULY 17, 2024

Bayer has claimed a second pivotal trial win for its blockbuster-to-be androgen receptor inhibitor Nubeqa, looking to reach the entire space of metastatic hormone-sensitive prostate cancer (mHSPC). | Bayer has claimed a second pivotal trial win for its blockbuster-to-be androgen receptor inhibitor Nubeqa, looking to reach the entire space of metastatic hormone-sensitive prostate cancer.

100

100

STAT

JULY 17, 2024

LONDON — Roche on Wednesday reported positive early data from another of the obesity drug candidates that it picked up through an acquisition late last year, bolstering the case it could become a player in the competitive weight-loss medicine field.   The company said its once-daily pill, called CT-996, led to a placebo-adjusted average weight loss of 6.1% after four weeks in patients with obesity who did not have diabetes.

124

124

Pharmacy Times

JULY 17, 2024

Many ways exist to best serve communities and the bottom line beyond vaccine ordering and increased staffing.

Vaccines 122

Vaccines 122

STAT

JULY 17, 2024

Faced with widespread skepticism about the value of digital therapies, Swing Therapeutics in early 2022 set out to make the strongest case possible for its app-based treatment for fibromyalgia. In a year-long pivotal trial for Swing’s treatment, called Stanza, participants were told they were receiving one of two potentially effective treatments for fibromyalgia.

FDA 117

FDA 117

Fierce Healthcare

JULY 17, 2024

Elevance Health beat the Street on both profit and revenue in the second quarter, according to its earnings report released on Wednesday.

115

115

STAT

JULY 17, 2024

Federal guidance restricting hospital websites’ use of third-party trackers along with the proliferation of direct-to-consumer health services is spawning a new crop of health tech startups promising to help beleaguered providers stay on the right side of the law. Among them is San Francisco startup Freshpaint, which on Wednesday announced a $30 million Series B round to sell its privacy platform to providers, pharmacies, insurers.

Insurance 115

Insurance Hospitals 115

pharmaphorum

JULY 17, 2024

Get insights into Dr James Burt's leadership as CEO of Pharmanovia through a 12-question interview that covers his background, achievements, and vision for the company.

100

100

STAT

JULY 17, 2024

Cassava Sciences is imploding — and as it crumbles, a dark, ugly corner of the Alzheimer’s disease world is being exposed and will hopefully get cleaned up. Remi Barbier, Cassava’s longtime CEO, has resigned and is also leaving the board, the company announced Wednesday. Lindsay Burns, Cassava’s senior vice president of neuroscience, is gone, too.

114

114

European Pharmaceutical Review

JULY 17, 2024

European Pharmacopoeia has confirmed it will remove the rabbit pyrogen test (RPT) from its monographs. This milestone decision was made during the Ph. Eur.’s 179th session in June 2024. The RPT has been the traditional detection method for pyrogens, the European Directorate for the Quality Of Medicines (EDQM) explained. In June 2021, the European Pharmacopoeia Commission (EPC) committed to completely replace the RPT in the 59 Ph.

98

98

STAT

JULY 17, 2024

A clutch of headlines last week suggested the U.S. Senate had achieved a breakthrough in the battle to prevent pharmaceutical companies from abusing the patent system, an issue that has been blamed for boosting prescription drug costs for Americans. But while the Senate bill  clearly represents a step forward, the impact will not be nearly as great as originally intended by lawmakers due to industry lobbying.

Pharmaceutical Companies 107

Pharmaceutical Companies Pharmaceutical Companies 107

Pharmacy Times

JULY 17, 2024

Currently, limited data show the effect of adverse drug events in the outpatient setting.

132

132

STAT

JULY 17, 2024

LONDON — A Novartis executive on Thursday said “it’s too early to say” whether the company would still submit an experimental myelofibrosis drug for regulatory approval this year, amid questions about the medicine’s data profile and whether it’s sufficient for filing. Novartis had previously said it planned to submit a marketing application for a rare bone marrow cancer drug called pelabresib to the Food and Drug Administration this year.

105

105

Fierce Pharma

JULY 17, 2024

Sanofi is looking to bulk up its workforce at its global capacity center in Hyderabad, India, with a multi-year investment totaling 400 million euros ($437 million), according to reports. | The drugmaker plans to grow it its workforce at the site to 2,600, making it the largest of Sanofi's four global capacity centers, according to reports.

95

95

pharmaphorum

JULY 17, 2024

Vertex Pharma has teamed up with Orum Therapeutics to develop a conditioning regimen, used to prepare patients to receive gene-editing medicines, that it hopes will offer a more tolerable alternative to current chemotherapy options.Vertex is paying $15 million upfront to get the ball rolling on the collaboration, which could be worth up to $945 million if it exercises options to use the technology for three developmental programmes and all of them hit various milestones.

Chemotherapy 90

Chemotherapy 90

STAT

JULY 17, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

88

88

Pharmaceutical Technology

JULY 17, 2024

In January, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist Party introduced the Biosecure Act.

98

98

Med Ed 101

JULY 17, 2024

Allergic rhinitis is a very common condition. I’ve encountered numerous patients throughout my career who take more than one medication to help keep their symptoms at bay. When reviewing polypharmacy cases, I do consider allergy medications as deprescribing targets because oftentimes allergy medications are added and the original success of the first agent is not […] The post Allergy Medications As Deprescribing Targets appeared first on Med Ed 101.

87

87

Fierce Pharma

JULY 17, 2024

As myriad pharma industry attempts to challenge the Inflation Reduction Act (IRA) fall flat, Johnson & Johnson is settling into a reality of pricing rebates and Medicare drug cost negotiations. | As myriad pharma industry attempts to challenge the Inflation Reduction Act (IRA) fall flat, Johnson & Johnson is settling into a reality of pricing rebates and Medicare drug cost negotiations.

85

85

pharmaphorum

JULY 17, 2024

Discover how artificial intelligence is revolutionising drug development and compliance in the pharmaceutical industry with these four impactful ways.

92

92

Fierce Healthcare

JULY 17, 2024

Four more community health centers are implementing Suki AI’s ambient scribe in their clinics, the company announced on Thursday. | Suki AI, an ambient scribe solution, says community health centers are able to afford Suki, unlike other AI solutions on the market. Stakeholders have wondered if the healthcare AI revolution will benefit small practices.

83

83